U.S. market Open. Closes in 6 hours 15 minutes

POAI | Predictive Oncology Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
Revenue1.78M1.51M1.42M1.25M1.41M1.41M654.84K456.50K654.35K951.56K468.12K188.77K96.64K288.0015.74KN/A
Cost of Revenue1.35M505.11K487.02K447.19K531.81K415.76K148.04K181.62K303.98K385.32K189.71K128.54K56.08K140.007.00KN/A
Gross Profit433.41K1.00M933.66K805.08K879.75K995.89K506.79K274.88K350.37K566.24K278.42K60.23K40.56K148.008.74KN/A
Operating Expenses14.35M16.27M14.41M13.29M14.65M8.86M8.25M6.80M4.75M7.03M9.21M7.22M4.15M1.21M2.45MN/A
Selling, General & Admin14.17M12.47M11.71M10.94M11.69M7.00M8.25M5.64M4.75M7.03M9.21M7.22M4.15M2.07M2.01M1.35M
Research & Development188.31K320.32K315.85K2.35M2.96M1.86MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating Expenses87.81K3.80M2.70M-1.58M-2.47M68.48KN/A1.16MN/AN/AN/AN/AN/A-868.29K447.00KN/A
Operating Income-13.92M-15.27M-13.47M-666.27K-13.77M-7.86M-7.75M-6.53M-4.40M-6.47M-8.93M-7.16M-4.11M-1.21M-2.44M-1.67M
Other Expenses / Income-62.64K-10.47M-6.85M-25.22M-5.62M-2.23MN/A-3.00-390.89K-366.12K-478.92K-262.46K-381.49KN/A-369.64KN/A
Before Tax Income-13.98M-25.74M-20.32M-25.88M-19.39M-10.09M-7.75M-6.53M-4.79M-6.83M-9.41M-7.42M-4.49MN/AN/AN/A
Income Tax Expenses4.0010.47M-661.66K11.82M8.17M-2.23MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-13.98M-36.21M-19.66M-37.70M-27.56M-10.09M-7.75M-6.53M-4.79M-6.83M-9.41M-7.42M-4.49M-1.35M-2.89M-1.76M
Interest ExpensesN/A10.65MN/AN/AN/AN/AN/A3.00390.89K377.72K636.50K259.35K230.37K147.09K78.94K89.34K
Basic Shares Outstanding4.01M3.65M2.74M597.51K143.51K64.08K636.30K282.33K15.52K11.96K8.10K3.71K1.29K746.00607.00552.00
Diluted Shares Outstanding4.01M3.65M2.74M597.51K143.51K64.08K636.30K282.33K15.52K11.96K8.10K3.71K1.29K746.00607.00552.00
EBITDA-13.18M-3.30M-6.68M358.58K-4.90M-7.71M-7.68M-6.44M-4.32M-6.39M-8.62M-7.16M-4.25M-1.20M-2.81M-1.67M
EBITDA Margin-740.52%-219.49%-470.16%28.63%-347.43%-546.43%-1,172.05%-1,411.55%-660.36%-671.82%-1,841.61%-3,793.85%-4,401.35%-417,773.26%-17,857.60%0.00%
EBIT-13.98M-15.09M-20.32M-25.88M-19.39M-12.31M-7.75M-6.53M-4.40M-6.46M-8.77M-7.16M-4.26M-1.21M-2.81M-1.67M
EBIT Margin-785.57%-1,002.18%-1,430.22%-2,066.99%-1,373.71%-872.14%-1,182.98%-1,429.59%-672.36%-678.45%-1,873.39%-3,794.42%-4,404.63%-418,616.67%-17,876.93%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙